会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Process for production of carotenoids, xanthophylls and apo-carotenoids utilizing eukaryotic microorganisms
    • 利用真核微生物生产类胡萝卜素,叶黄素和apo类胡萝卜素的方法
    • US20040253664A1
    • 2004-12-16
    • US10893636
    • 2004-07-16
    • Thomas Veach Long II
    • C12P023/00C12N001/12
    • C12P23/00A23K10/16A23K20/10A23K20/174A23K20/179A23K50/75A23K50/80A23L5/44A23L5/46A23L29/065A23L33/105
    • Disclosed is a method for producing an effective amount of one or more carotenoid, xanthophyll, or apo-carotenoid pigments from a microorganism from the Order Thraustochytriales. Suitable microorganisms put forth are of the genus Thraustochytrium and Schizochytrium. Preferred culture conditions and mediums are discussed. Examples are given of production of specific pigments, such as null-carotene, lutein, adonirubin, canthaxanthin, and astaxanthin, as are examples of methods of isolation of the pigment from the microorganism. Also disclosed is a food product that contains a microorganism from the Order Thraustochytriales, the microorganism having produced internally an effective amount of one or more carotenoid, xanthophyll, or apo-carotenoid pigments. The food product is used in a method for delivering one or more of the pigments to an animal or human for either pharmaceutical, nutritional or coloration purposes, by feeding the food product to the animal or human.
    • 本发明公开了一种从命令性破囊壶菌中产生有效量的一种或多种类胡萝卜素,叶黄素或脱辅胡萝卜素色素的方法。 合适的微生物属于Thraustochytrium属和Schizochytrium属。 讨论优选的培养条件和培养基。 给出了与微生物分离颜料的方法的实例,例如β-胡萝卜素,叶黄素,adonirubin,角黄素和虾青素等特定颜料的生产。 还公开了一种食品,其含有来自止咳药类的微生物,微生物在内部产生有效量的一种或多种类胡萝卜素,叶黄素或脱辅胡萝卜素色素。 该食品用于将药物,营养或着色目的中的一种或多种颜料递送给动物或人,方法是通过将食品喂给动物或人来输送。
    • 8. 发明申请
    • Retinal cell lines with extended life-span and their applications
    • 具有延长使用寿命的视网膜细胞系及其应用
    • US20030059868A1
    • 2003-03-27
    • US09559707
    • 2000-04-27
    • John GreenwoodPeter AdamsonRaymond Lund
    • C12P023/00C12P021/02C12N005/06C07H021/04C12N001/18
    • C12N5/0621A61K35/12C12N2503/00C12N2510/02C12N2510/04
    • The invention features retina-derived (retinal endothelial or retinal epithelial pigment) cell lines with extended life-span and capable of being implanted in the retina and of carrying a therapeutic substance to the eye and to the central nervous system. Such lines can also be used as a model for studying blood central nervous system interfaces. These lines are derived from primary retinal cultures selected from the group consisting of primary retinal endothelial cells and primary retinal epithelial cells, comprise a polynucleotide containing an oncogene, which polynucleotide is optionally associated with at least one selection gene, and have the morphological characteristics and at least the expression characteristics of the surface antigens of corresponding primary cultures.
    • 本发明特征在于视网膜衍生(视网膜内皮或视网膜上皮细胞色素)细胞系具有延长的寿命并且能够植入视网膜并且将治疗物质携带到眼睛和中枢神经系统。 这样的线也可以用作研究血液中枢神经系统界面的模型。 这些系衍生自选自原发性视网膜内皮细胞和原代视网膜上皮细胞的原代视网膜培养物,包含含有癌基因的多核苷酸,所述多核苷酸任选地与至少一个选择基因相关,并具有形态特征 最小表达相关原代培养物的表面抗原特征。